Background Although recent studies have reported that drug-coated balloons (DCB) are non-
inferior to drug-eluting stents (DES) for the treatment of native coronary arteries in a specific …

Previous midterm follow-up reports after implantation of the Absorb™ everolimus-eluting
bioresorbable scaffold (BRS; Abbott Vascular, Santa Clara, CA, USA) in stable coronary …

We aimed to quantitatively assess a possible difference of the neointimal quality between
biodegradable polymer-(BP-) and durable polymer drug-eluting stents (DP-DESs). We …

Background Patients with acute coronary syndrome (ACS) might represent a specific
subgroup, in which bioresorbable scaffold implantation in percutaneous coronary …

We aimed to assess a possible difference of the neointimal coverage status and its quality
after implantation of the current-generation metallic stents in patients with acute coronary …

Over the better part of two decades, lessons learned from stent failure have led to technical
advances that have resulted in current-generation metallic drug-eluting stents (DES) with …

Purpose Data regarding vessel healing by optical coherence tomography (OCT) after
everolimus-eluting bioresorbable scaffolds (BRS) or everolimus-eluting metallic stent (EES) …

The drug-coated balloon (DCB) angioplasty is considered a standard therapeutic option for
in-stent restenosis. In the present case, we observed high-intensity spots on optical …

Optical coherence tomography (OCT) was introduced into cardiovascular imaging in 19971,
emerging as a spin-off from an original scientific invention within the field of ophthalmology …